Factors Associated With Short Withdrawal Time and Polyp Detection Rate During Colonoscopy

NCT ID: NCT01487356

Last Updated: 2011-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

802 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Colonoscopy withdrawal times are a critical element in determining quality of colonoscopy; however, few studies have evaluated specific factors that may influence the duration of withdrawal, and specifically short withdrawal times. Other factors affecting polyp detection rate, one element of quality of colonoscopy, also need further study. By collecting data on hundreds of colonoscopies performed by 9 endoscopists, our goal was to identify factors associated with withdrawal time, inappropriately short withdrawal times, and polyp detection rate during colonoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Colonoscopy withdrawal times are a critical element in determining quality of colonoscopy; however, few studies have evaluated specific factors that may influence the duration of withdrawal, and specifically short withdrawal times. Other factors affecting polyp detection rate, one element of quality of colonoscopy, also need further study.

Objective:

To identify factors associated with withdrawal time, inappropriately short withdrawal times, and polyp detection rate during colonoscopy.

Design:

Data were prospectively collected (05/08-06/09) on 802 colonoscopies conducted by 9 blinded endoscopists, including patient age and sex, indication, colonoscope insertion and withdrawal time, biopsies performed, number/size of polyps and method of resection, bowel preparation quality, time of day, day of week, endoscopist, position of the procedure within the endoscopist's slate, and call status of the endoscopist.

Setting:

This study was conducted at a single tertiary care hospital, St. Paul's Hospital, in Vancouver, British Columbia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Polyps

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Colonoscopy quality assurance withdrawal time polyp detection rate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing colonoscopy

Data was collected on all adult patients undergoing outpatient colonoscopy at St. Paul's Hospital from May 2008 to June 2009. Exclusion criteria were prior colon resection and repeat colonoscopy for the purpose of endoscopic therapy for known lesions.

No intervention

Intervention Type OTHER

Colonoscopies were conducted as per the endoscopist's usual practice. No change in protocol was expected.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Colonoscopies were conducted as per the endoscopist's usual practice. No change in protocol was expected.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients undergoing colonoscopy at St. Paul's Hospital in Vancouver, BC.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rob Enns, MD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Paul's Hospital

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H10-00312

Identifier Type: -

Identifier Source: org_study_id